Home
About
Pricing
Log In
Back
GA8
Asset Logo

Goldarc Resources Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 18.00%
Annual Growth

5 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

7
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Goldarc Resources Limited

๐Ÿ“ˆ Performance

Price History

-87.33%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.04

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in GA8

7

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in GA8

N/A
GA8 investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

33%

Less than 50k

53%
๐Ÿ‘ถ Age of investors

18 - 25

14%

26 - 34

43%

35 - 90

43%
๐Ÿ™‹ Legal gender of investors

Female

57%

Male

43%

Pearlers who invest in GA8 also invest in...

Asra Minerals Limited

ASR

Asra Minerals Ltd. engages in the development and exploration of mineral properties. The company is headquartered in Perth, Western Australia. The firm is focused on targeting a growing gold, lithium and rare earth element (REE) portfolio in the premier Goldfields region of Western Australia. The Companyโ€™s flagship Mt Stirling Project is located 240 kilometers (km) north of Kalgoorlie and hosts 10 gold prospects, and a gold JORC Mineral Resource. The project also has a potential for REE and critical minerals including scandium. Its Kookynie West Project is situated less than 50km south, which is an underexplored site showing gold, lithium and REE potential. The company also has two lithium-focused exploration projects in the southern Yilgarn area of Western Australia at Lake Johnston and Lake Cowan, located in highly prospective ground between operating lithium mines at Earl Grey and Bald Hill. Its footprint in the Eastern Goldfields region stands at approximately 1,134 square kilometers (km2).

๐Ÿ™Œ Performance (5Yr p.a)

2.00%

๐Ÿ“Š Share price

$0.02 AUD

โ›๏ธ MINING

Find Out More

๐Ÿ™Œ Performance (5Yr p.a)

14.29%

๐Ÿ“Š Share price

$0.02 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ“Š Share price

$0.04 AUD

Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. The company holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Companyโ€™s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.

๐Ÿ™Œ Performance (5Yr p.a)

213.33%

๐Ÿ“Š Share price

$0.10 AUD

๐Ÿ“ฆ LOGISTICS

Want more shares? Try these...

๐Ÿ“Š Share price

$0.00 AUD
Compare
Add to watchlist